Literature DB >> 22609054

Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.

Tatsuya Fujikawa1, Hisashi Imbe, Masamichi Date, Yoshie Go, Haruko Kitaoka.   

Abstract

Insulin allergy is a rare complication of insulin therapy. Proper management, though difficult, is critical. Here, we report the case of a patient with type 2 diabetes and insulin allergy, successfully treated with continuous subcutaneous insulin infusion (CSII).
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609054     DOI: 10.1016/j.diabres.2012.04.027

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Allergy to soft cannula of insulin pump in diabetic patient.

Authors:  Yu-Min Chen; Hui Huang
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

2.  Rapid Desensitization for Insulin Allergy in Type 1 Diabetes Using an Insulin Pump: A Case Report and Literature Review.

Authors:  Kristy Tian; Haur Yueh Lee; Huee Boon Lim; Yoke Ling Chan; Ai Heong Chong; Suresh Rama Chandran; Daphne Su-Lyn Gardner
Journal:  AACE Clin Case Rep       Date:  2021-06-17

Review 3.  Hypersensitivity reactions to human insulin analogs in insulin-naïve patients: a systematic review.

Authors:  Andrew S Bzowyckyj; Amanda M Stahnke
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-26       Impact factor: 3.565

4.  Insulin allergy can be successfully managed by a systematic approach.

Authors:  Maija Bruun Haastrup; Jan Erik Henriksen; Charlotte Gotthard Mortz; Carsten Bindslev-Jensen
Journal:  Clin Transl Allergy       Date:  2018-09-25       Impact factor: 5.871

5.  Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report.

Authors:  Anh Dat Nguyen; Chinh Quoc Luong; Hieu Chi Chu; Van Khoa Dieu Nguyen; Chi Van Nguyen; Tuan Anh Nguyen; Quan Huu Nguyen; Ton Duy Mai; Dinh Van Nguyen; Bay Quang Nguyen; Thong Huu Tran; Phuong Viet Dao; Dat Tuan Nguyen; Nguyet Nhu Nguyen; Son Ngoc Do
Journal:  BMC Endocr Disord       Date:  2019-11-11       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.